Get the (PARS) Report Here
Trade with Jim Cramer 14 Days FREE
Pharmos skyrockets on positive results for its cannabinor pain treatment.
Whittier Energy shines.
Dexanabinol scores high on only one of six tests measuring cognitive function, but the next study remains key.
A drug synthesized from cannabinoid compounds targets brain traumas.
ViroPharma up after Schering-Plough licenses a cold drug.
The market has been grim, but a bounce should be imminent. Plus, charts of Apple, the S&P 500 and more.
Gary suggests a more refined way of using TA in trading. Also, charts on Juniper, the Nazz, and others.
©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.